Skip to main content
. 2022 Sep 1;58(9):1198. doi: 10.3390/medicina58091198

Table 1.

Clinical characteristics in controls and patients with sepsis (number, mean ± standard error mean).

No AKI
(n = 19)
AKI
(n = 17)
ESRD
(n = 8)
All Patients
(n = 44)
Controls
(n = 27)
Age (years) 76.3 ± 2.6 73.9 ± 2.5 77.0 ± 3.6 75.5 ± 1.6 60.3 ± 1.3 *
Male (%) 14 (73.7) 10 (58.8) 2 (25.0) 26 (59.1) 17 (63.0)
APACHE II score 18.0 ± 0.9 26.9 ± 1.0 27.8 ± 3.3 23.2 ± 1.1
SOFA score 8.5 ± 0.7 11.9 ± 0.9 12.3 ± 0.8 10.5 ± 0.6
History (%)
COPD 1 (5.3) 1 (5.9) 0 (0.0) 2 (4.5)
Heart failure 3 (15.8) 2 (11.8) 0 (0.0) 5 (11.4)
Hypertension 14 (73.7) 9 (52.9) 7 (87.5) 30 (68.2)
Diabetes mellitus 7 (36.8) 6 (35.3) 6 (75.0) 19 (43.2)
Old CVA 5 (26.3) 4 (23.5) 1 (12.5) 10 (22.7)
Liver cirrhosis 2 (10.5) 3 (17.6) 0 (0.0) 5 (11.4)
Active malignancy 1 (5.3) 1 (5.9) 0 (0.0) 2 (4.5)
Infection source
Pneumonia 13 (68.4) 13 (76.5) 3 (37.5) 29 (65.9)
UTI 3 (15.8) 0 (0.0) 2 (25.0) 5 (11.4)
Others 3 (15.8) 4 (23.5) 3 (37.5) 10 (22.7)
Adverse event
New arrhythmia 3 (15.8) 1 (5.9) 0 (0.0) 4 (9.1)
GI bleeding 1 (5.3) 3 (17.6) 0 (0.0) 4 (9.1)
Shock 8 (42.1) 11 (64.7) 6 (75.0) 25 (56.8)
Thrombocytopenia 5 (26.3) 7 (41.2) 3 (37.5) 15 (34.1)
Jaundice 3 (15.8) 5 (29.4) 0 (0.0) 8 (18.2)
Bacteremia 3 (15.8) 2 (11.8) 2 (25.0) 7 (15.9)
Body weight, kg 62.5 ± 3.6 60.6 ± 3.7 52.0 ± 4.3 59.9 ± 2.3 65.5 ± 1.9
Serum creatinine, mg/dL 1.25 ± 0.18 3.32 ± 0.36 6.25 ± 1.31 2.96 ± 0.39 0.88 ± 0.05 *
Urine output, mL/kg/h 0.97 ± 0.14 0.72 ± 0.17 0.05 ± 0.03 †,‡ 0.70 ± 0.10
28-day mortality 1 (5.3) 9 (52.9) 4 (50.0) 14 (31.8)

Abbreviations: AKI = acute kidney injury; ESRD = end-stage renal disease; APACHE = Acute Physiology and Chronic Health Evaluation; SOFA = Sequential Organ Failure Assessment; COPD = chronic obstructive pulmonary disease; CVA = cerebral vascular accident; UTI = urinary tract infection; GI = gastrointestinal. * p < 0.05, comparison with patients using t-test. p < 0.05, comparison with no AKI group using t-test or Fisher’s exact test. p < 0.05, comparison with AKI group using t-test.